> Identifying Oncogenic Variants in VarSeq

Identifying Oncogenic Variants in VarSeq

varseq Logo

About this webinar

September 20, 2023 // 12:00 PM EST

Presented By: Nathan Fortier, Director of Research

The interpretation of somatic variants can be a challenging process. While AMP Guidelines provide detailed rules for accessing the clinical evidence associated with a specific variation, they do not specify criteria for determining if a variant is likely to be a driver mutation, which generates functional changes that enhance tumor cell proliferation. In this webcast, we will discuss a new VarSeq algorithm for estimating the oncogenicity of a variant. This will include a deep dive into our oncogenicity scoring system and a discussion of the various criteria used to distinguish driver mutations from benign variations and variants of uncertain significance.

What you will learn in this webcast:
  • How to use the scoring algorithm to identify variants with evidence of oncogenicity
  • Which criteria are used to assess a variant's oncogenicity
  • How to evaluate the oncogenicity of a variant in VSClinical
  • Watch on demand

    Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.

    Download the slide deck

    To download a copy of the slides, click on the LinkedIn icon. This will redirect you to the SlideShare site. From there, you can clip your favorite slides or download the entire deck to your computer.

    Love this webcast? Check out more!

    Find out how Golden Helix software enables users to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.